Highline Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Highline Wealth Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,765	Closed	-$272K	–	1169
2025 Q3	$272K	Sell	2,765 -1,870	-40%	-$185K	0.07%	91
2025 Q2	$423K	Sell	4,635 -6	-0.1%	-$580	0.13%	73
2025 Q1	$525K	Sell	4,641 -12	-0.3%	-$1.28K	0.18%	67
2024 Q4	$491K	Sell	4,653 -2	-0%	-$215	0.16%	72
2024 Q3	$503K	Buy	4,655 +18	+0.4%	+$1.96K	0.17%	73
2024 Q2	$503K	Buy	4,637 +2	+0%	+$236	0.19%	75
2024 Q1	$612K	Hold	4,635	–	–	0.25%	69
2023 Q4	$564K	Hold	4,635	–	–	0.27%	72
2023 Q3	$520K	Hold	4,635	–	–	0.32%	69
2023 Q2	$675K	Hold	4,635	–	–	0.42%	57
2023 Q1	$599K	Hold	4,635	–	–	0.41%	61
2022 Q4	$591K	Hold	4,635	–	–	0.44%	63
2022 Q3	$485K	Buy	+4,635	New	+$509K	0.39%	59

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Highline Wealth Partners's ZBH Position: Q4 2025 in Review

Highline Wealth Partners sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,765 shares — an estimated $272K sold.

Highline Wealth Partners first reported a position in ZBH in Q3 2022 and held it in 13 quarters. The position peaked at $675K in Q2 2023. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Highline Wealth Partners reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Highline Wealth Partners sold 2,765 Zimmer Biomet shares in Q4 2025, an estimated $272K.
Highline Wealth Partners first reported a position in Zimmer Biomet in Q3 2022 and held it in 13 quarters.
Highline Wealth Partners's Zimmer Biomet position peaked at $675K in Q2 2023.
945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Highline Wealth Partners's 13F filing for Q4 2025, filed 15 Jan 2026.